The relationship between psychological stress and the clinical course of multiple sclerosis. An update;Zur beziehung von psychologischem stress und klinischem verlauf der multiplen sklerose

PPmP Psychotherapie Psychosomatik Medizinische Psychologie

Volumn 51, Issue 3-4, 2001, Pages 166-175

  Strenge, H ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytokine; Lymphocyte; Multiple Sclerosis; Stress

Indexed keywords

CYTOKINE;

ANXIETY; ARTICLE; BEREAVEMENT; CONFLICT; DEPRESSION; DISEASE EXACERBATION; HUMAN; LYMPHOCYTE; MENTAL STRESS; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL SUPPORT;

DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; STRESS, PSYCHOLOGICAL;

EID: 0035069235     PISSN: 09372032     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12378     Document Type: Article

References (124)

1. Immunologic response to acute psychological stress in MS patients and controls
2. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study
3. How should we proceed with disease-modifying treatments for multiple sclerosis?
4. Control and intrusive memories as possible determinants of chronic stress
5. Streßachse, Depression und Schlafstörungen. Die Rolle von Cortisol und yon Serotonin
6. Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats
7. Clinical and biological aspects of bereavement and loss-induced depression: A reappraisal
8. Acute and chronic responses to psychological trauma: Where do we go from here?
9. Emotional stress in relation to attacks of multiple sclerosis
10. A correlational study of disabilities, stressors and coping methods in victims of multiple sclerosis
11. 2, pH, and disodium edetate
12. Types of stressors that increase susceptibility to the Common cold in healthy adults
13. Psychological stress and susceptibility to the common cold
14. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity
15. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
16. Group psychotherapy: Benefits in multiple sclerosis
17. Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis
18. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis
19. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
20. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults
21. Mood disorders and dysfunction of hypothalamic-pituitary-adrenal axis in multiple sclerosis: Association with cerebral inflammation
22. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance
23. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures
24. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis
25. Efficacy of stress-inoculation training in coping with multiple sclerosis
26. A prospective study of depression and immune dysregulation in multiple sclerosis
27. An analysis of coping in a middle-aged community sample
28. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone
29. A controlled study of potential risk factors preceding exacerbation in multiple sclerosis
30. Multiple sclerosis associated with sinusitis: Case-controlled study in general practice
31. Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS
32. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury
33. Depression, cognitive impairment and social stress in multiple sclerosis
34. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine
35. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation
36. The relationship of MS to physical trauma and psychological stress
37. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis
38. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis
39. Influence of temperature changes on multiple sclerosis: Critical review of mechanisms and research potential
40. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
41. Neuroimmunologie und multiple Sklerose
42. Stress and immunity in humans: A metaanalytic review
43. Multiple Sklerose
44. Can emotional conflict induce disseminated sclerosis?
45. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus
46. Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew
47. Life events, depressive symptoms, and immune function
48. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta
49. Psychological and neuropsychological predictors of coping patterns by patients with multiple sclerosis
50. Formation of ion-permeable channels by tumor necrosis factor-alpha
51. Interleukin-12: Amiss in MS
52. Immunomodulating therapeutic approaches for multiple sclerosis
53. Marital quality, marital disruption, and immune function
54. Psychosocial modifiers of immunocompetence in medical students
55. Psychoneuroimmunology: Can psychological interventions modulate immunity?
56. Spousal caregivers of dementia victims: Longitudinal changes in immunity and health
57. Negative behavior during marital conflict is associated with immunological down-regulation
58. Emotion and immunity
59. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy
60. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis
61. The influence of stress intrusion on immunodepression in generalized anxiety disorder patients and controls
62. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12
63. It's long-term stressors that take a toll Comment on Cohen et al (1998)
64. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer
65. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients
66. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
67. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response
68. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety
69. Cytokine dysregulation associated with exam stress in healthy medical students
70. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
71. Interferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis
72. Protective and damaging effects of stress mediators
73. The path to damage in multiple sclerosis
74. The role of psychological process in a somatic disorder: Multiple sclerosis. 1. The emotional setting of illness onset and exacerbation
75. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function
76. Treatment of multiple sclerosis with copolymer-1 (Copaxone): Implicating mechanisms of Th1 to Th2/Th3 immune-deviation
77. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis
78. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment
79. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
80. Immunmodulatorische Stufentherapie der multiplen Sklerose
81. Die Rolle des Zytokinnetzwerks im ZNS und psychische Störungen
82. Laienätiologie und Krankheitsverarbeitung bei schweren körperlichen Erkrankungen. Eine empirische Vergleichsstudie mit Herzinfarkt-, Krebs-, Dialyseund MS-Patientinnen
83. Immunological changes in young and old adults during brief laboratory stress
84. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
85. Psychological stress as risk factor for exacerbations in multiple sclerosis
86. A new approach to affective symptoms in relapsing-remitting multiple sclerosis
87. Effect of diagnostic testing for multiple sclerosis on patient health perceptions
88. Editorial: The search for the elusive psychosocial modulators of human immunodeficiency virus disease progression
89. Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment
90. Influence of infection on exacerbations of multiple sclerosis
91. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system
92. The etiologic significance of emotional factors in onset and exacerbations of multiple sclerosis. A preliminary report
93. Trauma, stress, and multiple sclerosis
94. Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis
95. Structural brain correlates of emotional disorder in multiple sclerosis
96. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients
97. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
98. Anxiety in patients with multiple sclerosis
99. Paroxysmal kinesigenic choreoathetosis as presenting symptom of multiple sclerosis
100. Increased depression in multiple sclerosis patients. A meta-analysis
101. Teaching coping skills enhances quality of life more than peer support: Results of a randomized trial with multiple sclerosis patients
102. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin
103. Association between tumor necrosis factor-a and disease progression in chronic progressive multiple sclerosis
104. Intercellular adhession molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6
105. Risk factors in multiple sclerosis
106. Clinical viral infections and multiple sclerosis
107. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibers
108. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
109. Multiple sclerosis: Correlation of anxiety, physical impairment and cognitive dysfunction
110. Suicide and multiple sclerosis: An epidemiological investigation
111. Psychological correlates of health care utilization in chronic illness
112. Rupprecht Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis
113. Multiple sclerosis. Therapeutic update
114. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
115. Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients
116. Emotional stress and the development of multiple sclerosis: Case-control evidence of a relationship
117. Emotional stress and coping in multiple sclerosis (MS) and exacerbations
118. The neuroendocrine axis in patients with multiple sclerosis
119. Verwendung paramedizinischer Verfahren durch MS-Patienten - Patientencharakterisierung und Anwendungsgewohnheiten
120. Chronic relapsing experimental allergic encephalomyelitis. An experimental model of multiple sclerosis
121. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury
122. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells
123. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder
124. Cortisol regulation in posttraumatic stress disorder and major depression: A chronobiological analysis